Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Implementation of colorectal cancer screening with Faecal Occult Blood Test (FOBT) in the Netherlands

ABSTRACT: Study hypothesis: Implementation of colorectal cancer screening with Faecal Occult Blood Test (FOBT) in the Netherlands is feasible. Please note that the follow-up study to this randomised controlled trial can be found at ISRCTN94861265: Screening Or NO Screening: differences in survival during follow-up after random colorectal cancer screening with faecal occult blood test or no screening. Primary outcome(s): Response rate per FOBT, measured at T2.

DISEASE(S): Colorectal Cancer Screening With Faecal Occult Blood Test (fobt),Mass Screening, Occult Bleeding, Response Rate, Colorectal Cancer

PROVIDER: 2420163 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

ACCESS DATA

Json Xml

Similar Datasets

Screening Or NO Screening: differences in survival during follow-up after random colorectal cancer screening with faecal occult blood test or no screening

Project description:Study hypothesis: Survival after screening for colorectal cancer with faecal occult blood test is increased compared with no screening. Please note that this is the follow-up trial to ISRCTN57917442: Implementation of colorectal cancer screening with Faecal Occult Blood Test (FOBT) in the Netherlands. Primary outcome(s): Survival In each year of the follow-up (timepoints T9 - T11), the population will be censored for: 1. Mortality of colorectal cancer 2. Mortality of other causes 3. Other reasons for loss to follow-up

| 2426425 | ecrin-mdr-crc

Mailing of the Faecal Occult Blood Test (FOBT) to increase compliance to colorectal cancer screening and to reduce costs

Project description:Study hypothesis: European Commission Guidelines on cancer prevention recommend to the member states the implementation of colorectal cancer screening programmes based on the Faecal Occult Blood Test (FOBT) every two years in the population 50-70 years old. In Italy, colorectal cancer screening is affected by low compliance. Furthermore the front office activities to give the faecal sampler to the participants are time and cost consuming. A direct mailing strategy of the faecal sampler could increase compliance and could reduce the resource consumption of the front office activities. Primary outcome(s): Compliance to screening at 60 days after mailing (of the FOBT or of the letter).

| 2408138 | ecrin-mdr-crc

Screening for Colorectal Cancer With FOBT, Virtual Colonoscopy and Optical Colonoscopy. A Randomized Clinical Trial in the Florence District

Project description:RATIONALE: Computed tomographic colonography (CTC) has proven to be accurate in detecting colorectal neoplasms and may be a primary test in colorectal cancer screening. PURPOSE: This clinical trial will compare participation rate, diagnostic yield and costs of computed tomographic colonography, faecal occult blood test (FOBT) and colonoscopy (CO) as a primary screening test in a population-based programme.

| 2129368 | ecrin-mdr-crc

Follow-up-IBS

Project description:Follow-up of faecal microbiota in IBS patients

| PRJEB3227 | ENA

First approach on the use of samples from fecal occult blood screening kits for metabolomic analysis. Application in colorectal cancer population.

Project description:Cancer is the most common disease around the world and colorectal cancer is the second most common cancer. The early diagnosis of colorectal cancer is difficult and relies on invasive diag-nostic tools such as colonoscopy and tissue biopsy. Other non-invasive techniques such as fecal occult blood screening test (FOBT) are less sensitive and accurate. The advantage of FOBT together with high throughput technology such as metabolomics could provide the advantages of non-invasive tool and the effectiveness of detecting novel colorectal cancer markers. In this way, this work focuses on the novelty of using FOBT as samples to perform metabolomics analysis and its application on colorectal cancer population.

2022-12-09 | ST002468 | MetabolomicsWorkbench

The FLU-FOBT Program in Primary Care Settings Where Disparities Persist

Project description:The investigators overall goals are to adapt, implement, evaluate, and disseminate the FLU-FOBT Program as an integrated nurse-run, primary care-based intervention that can reduce colorectal cancer screening disparities in resource-poor clinical settings. In this program, fecal occult blood tests (FOBT) are provided with influenza vaccinations (FLU) to eligible patients between the ages of 50 and 75 during FLU season. The investigators hypothesis is that the FLU-FOBT Program can be adapted for primary care settings and lead to higher rates of colorectal cancer screening (CRCS).

| 2095822 | ecrin-mdr-crc

Strategies for colorectal cancer screening with FOBT

Project description:Interventions: Medical Device : All participants were randomly allocated into two groups of equal size according to sex, age, and income level : a intervention group using FOBT kit (n=1,798)and a control group using stool container(n=1,798). Each group were devided into two supgroups to approach participants : mailing versus visiting hospital. Primary outcome(s): Compliance and examination result of fecal occult blood test according to FOBT kit and stool container Primary Purpose : Screening, Intervention Model : Parallel, Blinding/Masking : Open, Allocation : RCT

| 2509107 | ecrin-mdr-crc

Does the Invitation by the General Practitioner Improve Patients’ Participation in Colorectal Cancer Screening?

Project description:The propose of this study is to assess the effect of general practitioner’s involvement on first patients’ solicitation in screening for colorectal cancer by testing for faecal occult blood (FOBT).

| 2101012 | ecrin-mdr-crc

Screening for Colorectal Cancer in Recipients of Kidney Transplants

Project description:Interventions: 1. Faecal occult blood testing (FOBT). Participants will perform FOBT following enrolment. This involves using a patient kit to sample their own stools for the presence of blood, mailing their testing kit in to a central lab once it is completed. Testing will be conducted once but may involve sampling several stools. 2. Colonoscopy. All participants will also undergo colonoscopy following the completion of FOBT, regardless of the result. This will be performed within a target of 3 months post enrolment. Primary outcome(s): Sensitivity and specificity of faecal occult blood testing for colorectal cancer and colorectal neoplasia, using colonscopy as the gold standard procedure.[One-off screening with both FOBT and colonoscopy, with a completion target of 3 months post enrolment.] Study Design: Purpose: Screening;Duration: Cross-sectional;Selection: Defined population;Timing: Prospective

| 2453871 | ecrin-mdr-crc

Porcine epidemic diarrhea in Europe

Project description:COMPARE H5N8 Follow-up

| PRJEB19037 | ENA